title: Is anti-doping analysis so far from clinical, legal or forensic targets?: The added value of close relationships between related disciplines.
abstract: There are many areas of common interest between anti-doping laboratories and those working in the clinical, legal and forensic fields. In addition to methodological similarities, there are aspects of the findings in sport drug testing that overlap with other fields in such a way that sport drug testing and clinical, legal or forensic work may benefit from mutual interaction. Three recent examples are presented from the author's experience. Case report 1 concerns the clinical relevance of hCG findings in sport drug testing as potential indicators of the presence of a (testicular) tumour in athletes. Case report 2 refers to difficulties that accredited laboratories can encounter due to differences between national legal systems and the administrative regulation systems of sport authorities. The example involves a network of blood collection for further autologous transfusion. Case report 3 relates to additional forensic-type investigations needed to interpret a situation where intoxication of a whole delegation was responsible for apparent doping cases. Clinical, legal and forensic fields must recognize the added value that some results and developments coming from anti-doping laboratories may have. At the same time anti-doping analysts should be aware of new issues, methodologies and problems appearing in related fields.
authors.affiliation: Bioanalysis Research Group, IMIM-Hospital del Mar, Dr Aiguader 88, Barcelona, Spain. jsegura@imim.es
authors.forename: Jordi
authors.initials: J
authors.lastname: Segura
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood; D001803:Blood Transfusion / Q000331:legislation & jurisprudence; D004300:Doping in Sports / Q000331:legislation & jurisprudence*; D005260:Female; D005554:Forensic Medicine; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000633:toxicity; D015813:Substance Abuse Detection / Q000379:methods*
chemical_list: D014408:Biomarkers, Tumor; D018817:N-Methyl-3,4-methylenedioxyamphetamine